The event is scheduled for September 27, 2026, in Arlington, Virginia. The presentations will address the diagnostic’s use in clinical practice and research involving veteran and military populations.
The studies evaluated adults with chronic spontaneous urticaria whose symptoms were inadequately controlled by H1-antihistamines. Across both trials, 1,939 patients were randomized to barzolvolimab or placebo. The two dosing groups were 150 mg Q4W and 300 mg Q8W.
Nasdaq Confirms $1.00 Bid Requirement Met
Compass Therapeutics, Inc. (NASDAQ: CMPX) is a Pharmaceuticals: Major company. FDA feedback now calls for survival-benefit evidence before aBiologicslicense application for tovecimig in previously treated, advanced biliary tract cancer. Compass Therapeutics says it does not believe another trial is warranted before a BLA based …
CTT PHARMACEUTICAL HOLDINGS, INC. (OTC: CTTH), identified in the transaction as its CEO, bought 10,100 shares at $0.04 per share on 22 September 2026. CTTH is a Pharmaceuticals: Major company.
CYBIN INC. (NASDAQ: HELP) is a major pharmaceuticals company. Its commercial operating name, Helus Pharma, will have Chief Executive Officer Michael Halstead participate in a virtual fireside chat at the TD Cowen Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026.
Enlivex Ltd. (NASDAQ: ENLV) is a biotechnology company. It ended a proposed private placement involving 66,666,667 ordinary shares, removing the planned share issuance from the transaction described with the Rain Foundation. The agreement had been signed on July 27, 2026. The Rain Foundation was …
Filana Therapeutics, Inc. (NASDAQ: FLNA) is a biotechnology company. The FDA has lifted its clinical hold on Filana’s investigational new drug application for simufilam, allowing the planned proof-of-concept study in TSC-related epilepsy to advance.
PERMA FIX ENVIRONMENTAL SERVICES INC (NASDAQ: PESI) is an Environmental Services company. TheBusinessmade an updated investor presentation available on September 22, 2026.
Oasis Management Co Ltd. raised its Vail Resorts stake to 7.4%, holding 2,622,562 common shares under an activist Schedule 13D. Investors can see the reported ownership level alongside the Oasis Fund’s disclosed purchase details and the holdings attributed to other named reporting persons.Key HighlightsOasis …